SCHEMBL7130864

SCHEMBL7130864

c1cnn(-c2nc(NCc3ccc4c(c3)OCCO4)c3c4c(sc3n2)CCCC4)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 8/20 0.45
MAPT P10636 5/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
NPSR1 Q6W5P4 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PDE5A O76074 1/20 0.41
ALDH1A1 P00352 6/20 0.41
MAPK1 P28482 3/20 0.41
POLB P06746 2/20 0.41
TSHR P16473 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 6/20 0.40
ALOX15 P16050 3/20 0.40
USP2 O75604 2/20 0.40
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5777790 0.95 PTPN12 (0.45) HTTMAPTSMN1; SMN2NPSR1MEN1
SCHEMBL7121344 0.87 HTT (0.47) HTTMAPTSMN1; SMN2NPSR1MEN1
SCHEMBL5781513 0.86 ALDH1A1 (0.44) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL5782312 0.86 HTT (0.45) HTTMAPTSMN1; SMN2NPSR1MEN1
SCHEMBL5781621 0.85 PDE5A (0.57) HTTMAPTSMN1; SMN2NPSR1MEN1
SCHEMBL5801995 0.85 NOS2 (0.46) HTTMAPTSMN1; SMN2NPSR1MEN1
SCHEMBL5781158 0.85 MEN1 (0.53) HTTMAPTSMN1; SMN2NPSR1MEN1
SCHEMBL5128714 0.84 ALDH1A1 (0.47) HTTMAPTSMN1; SMN2NPSR1MEN1
SCHEMBL5781706 0.83 HTT (0.48) HTTMAPTSMN1; SMN2NPSR1MEN1
SCHEMBL5777938 0.83 MAPT (0.47) HTTMAPTSMN1; SMN2NPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0920431-B1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2003-02-26 EP disclosed
US-6432950-B1 ANTICANCER AGENTS; KILLING CANCER CELLS CELL PATHWAYS 2002-08-13 US disclosed
US-6133271-A Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives CELL PATHWAYS, INC. (US) 2000-10-17 US disclosed
US-6110920-A TREATMENT OF CARDIOVASCULAR DISORDERS AND IMPOTENCY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-29 US disclosed
EP-0920431-A1 THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 1999-06-09 EP disclosed
WO-1998006722-A1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 1998-02-19 WO disclosed